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Structure and Properties of an Under-sulfated
Heparan Sulfate Proteoglycan
Synthesized by a Rat Hepatoma Cell Line
ABSTRACT
￿
A rat hepatoma cell line was shown to synthesize heparan sulfate and chondroitin
sulfate proteoglycans. Unlike cultured hepatocytes, the hepatoma cells did not deposit these
proteoglycans into an extracellular matrix, and most of the newly synthesized heparan sulfate
proteoglycans were secreted into the culture medium . Heparan sulfate proteoglycans were
also found associated with the cell surface. These proteoglycans could be solubilized by mild
trypsin or detergent treatment of the cells but could not be displaced from the cells by
incubation with heparin. The detergent-solubilized heparan sulfate proteoglycan had a hydro-
phobic segment that enabled it to bind to octyl-Sepharose. This segment could conceivably
anchor the molecule in the lipid interior of the plasma membrane. The size of the hepatoma
heparan sulfate proteoglycans was similar to that of proteoglycans isolated from rat liver
microsomes or from primary cultures of rat hepatocytes. Ion-exchange chromatography on
DEAE-Sephacel indicated that the hepatoma heparan sulfate proteoglycans had a lower
average charge density than the rat liver heparan sulfate proteoglycans. The lower charge
density of the hepatoma heparan sulfate can be largely attributed to a reduced number of N-
sulfated glucosamine units in the polysaccharide chain compared with that of rat liver heparan
sulfate. Hepatoma heparan sulfate proteoglycans purified from the culture medium had a
considerably lower affinity for fibronectin-Sepharose compared with that of rat liver heparan
sulfate proteoglycans. Furthermore, the hepatoma proteoglycan did not bind to the neoplastic
cells, whereas heparan sulfate from normal rat liver bound to the hepatoma cells in a time-
dependent reaction. The possible consequences of the reduced sulfation of the heparan
sulfate proteoglycan produced by the hepatoma cells are discussed in terms of the postulated
roles of heparan sulfate in the regulation of cell growth and extracellular matrix formation.
Heparan sulfate proteoglycans are present in a large variety
ofvertebrate tissues and appear to be preferentially located at
the surface of cells, either directly associated with the cell
membrane (1) or in close contact with cells, as in basement
membranes (2) and in the pericellular matrix ofcultured cells
(3,4).
Previous studies in our laboratory have indicated that hepa-
ran sulfate proteoglycans are associated with the plasma mem-
brane of rat liver cells by two independent mechanisms (5).
The proteoglycan may be bound via its polysaccharide portion
to cell surface receptors, or the core protein may be inserted
into the lipid interior of the membrane (6).
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The mechanisms responsible for the anchorage of heparan
sulfate in the basement membrane or in extracellular matrices
are not clear. Immunofluorescent studies have shown a co-
distribution between heparan sulfate proteoglycans and fibro-
nectin in the extracellular matrix (7, 8) and a direct binding
of heparan sulfate chains to fibronectin has been demon-
strated (7, 9).
Transformed cells usually do not assemble an extracellular
matrix (10-12), although exceptions to this rule have been
observed(12). Theirinability to form a matrix does not appear
to be caused by failure of the transformed cells to synthesize
any of the identified matrix components (13). It is possible,
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on structure as well as on the quantity of the synthesized
matrix components. In several systems, transformed cellshave
been shown to produce a heparan sulfate that has a reduced
sulfate content compared with the proteoglycan synthesized
by the normal counterpart (14-16).
The pericellular location of the heparan sulfate proteogly-
cans enables them to interact directly with cellsand may allow
these molecules to affect the behavior of cells. Recent interest
has focused on the possibility that heparan sulfate may regu-
late cell proliferation (17-20). In particular, mucopolysaccha-
rides isolated from normal rat liver were found to reduce the
rate of proliferation of cultured hepatoma cells(21).
The current study was undertaken to investigate the hy-
pothesis that structural differences in the heparan sulfate
proteoglycan produced by transformed cells result in an im-
paired function ofthe proteoglycan in terms of its interaction
with other molecules.
MATERIALS AND METHODS
Materials: The hepatoma cells were obtained from Dr. Eve Briles,
University of Alabama, Birmingham. ["S]Sulfate (carrier-free) was purchased
from the Radiochemical Centre, Amersham, England and 6-['H]glucosamine
(20.2 Ci/mmol) from New England Nuclear, Boston, MA. Heparin and bovine
liver heparan sulfate were prepared as previously described (5) and chemically
labeled with tritium by acetylation of free amino groups with ['H]acetic
anhydride (22). Heparan ["S]sulfate proteoglycans isolated from cultured rat
hepatocytes as described (5) were a gift from Dr. L. Kjellén, Uppsala, Sweden.
Trypsin (pancreatic, type II), soybean trypsin inhibitor, DNase I (DN-25),
papain (twice crystallized, type III), and BSA were obtained from Sigma
Chemical Co., St. Louis, MO. Chondroitinase ABC was purchased from Miles
Laboratories, Inc., Elkhart, IN. DEAE-Sephacel, Sepharose CL-4B, Sephadex
G-50 and G-200, octyl-Sepharose, Percoll, and dextran sulfate were from
Pharmacia Fine Chemicals, Uppsala, Sweden. Fibronectin was purified from
human plasma using the procedure ofVuento and Vaheri (23) and coupled to
CNBr-activated Sepharose (Pharmacia Fine Chemicals) according to the man-
ufacturer's directions. Eagle's a-modified minimal essential medium (MEM)
(catalogue number 12-313), t.-glutamine, and fetal calf serum were purchased
from Flow Laboratories, Inc., McLean, VA. Culture flasks, Petri dishes, and
16-mm well dishes were obtained from Costar Data Packaging, Cambridge,
MA. Therabbit antiserum to basementmembrane heparan sulfateproteoglycan
(BMI) was a kind gift from Dr. John Hassell, National Institutes of Health,
Bethesda, MD (24). The rabbit antiserum raised against rat fbronectin has
beendescribed(25). Goat anti-rabbit IgGantiserum conjugated withfluorescein
isothiocyanate (Miles Laboratories, Inc.) was diluted 1:50 before use.
Indirect Immunofluorescence:
￿
Hepatoma cells were grown on
coverslips and fixed with 3.5% paraformaldehyde. Unspecific binding siteswere
blocked by incubating the cells with 1% BSA in PBS. After a thorough wash,
the cellswere incubated at 37°C for45 min with rabbit antibodies raised against
either basement membrane heparan sulfate proteoglycan or against rat plasma
fibronectin. These antibodies were then visualized by incubation of the cells
with a second antibody, goat anti-rabbit gamma globulin conjugated with
fluorescein isothiocyanate. No staining was observed in controls where cells
were stained with the second antibody only.
Isolation of Radiolabeled Proteoglycans Synthesized by
Cultured Hepatoma Cells:
￿
Hepatoma cells were seeded in 50.0-ml
culture flasks in 5.0 ml of a-modified MEM supplemented with 10% fetal calf
serum and 0.03 mg/ml t.-glutamine. Radioisotope was added at the time of
seeding (50 pCi/ml of ["S]sulfate or 20 yCi/ml of ['H]glucosamine), and the
flasks were incubated at 37°C for 48 h.
After the incubation, the culture media were collected and centrifuged to
remove detached cells. The proteoglycans that were subsequently isolated from
the supernatant (see below) were denoted medium proteoglycans. The cell layer
was washed three times with PBS and then solubilized by treatment first with
2% Empigen BB in 0.1 mM HEPES, pH 7.4, containing protease inhibitors
(the proteaseinhibitors 5 mM benzamidine HCI,0.1 mM phenylmethylsulfonyl
fluoride, and 10 mM EDTA were used in all buffers) for 20 min at room
temperature, followed by the addition of an equal volume of 8.0 M GuHCI/
2% Triton X-100 in0.1 M HEPESbuffer, pH 7.4. The cell extract wasincubated
at 4°C on an end-over-end mixer for 30 min and then dialyzed against 0.05 M
Tris-HC1, pH 8.0, containing 0.1 % Triton X-100. The proteoglycans isolated
from the dialyzed cell fraction were designated cell-associated proteoglycans.
The samples were applied to columns (I x 3 cm) of DEAF-Sephacel at 4°C.
The columns were washed with 0.35 M NaCI in 0.05 M Tris-HCI, pH 8.0, and
eluted by a linear gradient from 0.35 to 1.50 M NaCl in 0.05 M acetate, pH
4.0. The buffers used in processing the cell-associated proteoglycans were
supplemented with 0.1 % Triton X-100.
To remove chondroitin sulfate proteoglycans, the proteoglycan mixture was
dialyzed for 24 h against 0.05 M Tris-HCI buffer, pH 8.0, and then digested
with chondroitinase ABC according to the procedure described previously (26).
The digest mixtures were applied to a column (107 x 1.2 cm) of Sephadex G-
50 equilibrated with 0.5 M NaCl. The chondroitinase ABC degradation prod-
ucts were eluted close to the total volume of the column. The material eluting
in the void volume was heparan sulfate, as indicated by its susceptibility to
nitrous acid treatment at pH 1 .5 (27).
Purification of Heparan Sulfate Proteoglycans from Rat Liver
Microsomes:
￿
Heparan sulfate proteoglycans labeled in vivo with ['SS]-
sulfate or ['H]glucosamine were purified from rat liver microsomes using a
procedure previously described (28) with the following additional steps. The
microsomal preparation was suspended in 0.35 M NaCl in 0.05 M Tris-HCl
buffer, pH 8.0, containing 0.1 mg/ml of dextran sulfate. The suspension was
incubated at 4°C in an end-over-end mixer for 30 min and then centrifuged at
35,000g for 30 min. This procedure released theheparan sulfate proteoglycans
bound to the plasma membranes via polysaccharide-receptor interactions (5).
Radioactively labeled heparan sulfate proteoglycans were isolated from the
supernatant by ion-exchange chromatography on DEAE-Sephacel as described
above.
Estimation of Molecular Size:
￿
The molecular sizes of heparan
sulfate proteoglycans were estimated by gel chromatography on a column (98
x 1 .2 cm) of Sepharose CL-4B eluted with 4 M GuHCl in 0.05 M Tris-HCI,
pH 8.0. The column was calibrated with reduced and alkylated proteins of
known molecular weights (phosphorylase b, 94,000 mol wt; a-chains of fibrin-
ogen, 70,000 mol wt; heavy chains of IgG, 53,000 moll wt). Previous studies
have shown that this method is reliable for determining the molecular weight
ofheparan sulfate proteoglycans isolated from rat livers (28).
The sizes of the polysaccharide chains cleaved from the proteogfycan core
protein by alkaline/borohydride treatment (0.05 M NaOH, 1 .0 M NaBH4 at
45°C for 24 h) were determined by gel chromatography. The neutralized
reaction mixtures were appliedto a column (105 x 1 .2 cm) of Sephadex G-200
equilibrated and eluted with 0.2 M NaCl at a flow rate of4 ml/h. The relative
molecular weights of the polysaccharide chains were estimated from their &,.
values using the calibration curve of Wasteson (29) obtained from chondroitin
sulfates.
Nitrous Acid Deamination:
￿
Two methods of nitrous acid deami-
nation were used. One involves treatment ofthe polysaccharides at pH 1.5 and
results in the cleavage ofN-sulfated glucosamine residues, whereas N-unsubsti-
tuted and N-acetyaated hexosamine units are left intact (27). This procedure
was used to quantitate the proportion of heparan sulfate in a mixture of
glycosaminoglycans. In the other method, the pH 1 .5 procedure is followed by
a second treatment at pH 3.9 (30). This method resulted in the cleavage ofN-
sulfated and N-unsubstituted glucosamine residues but not of N-acetyaated
hexosamine units. The extent ofdegradation ofthe heparan sulfate chains was
estimated after fractionation of the deamination mixtures on a column (62 x
0.6 cm) of Sephadex G-50.
Release ofCell Surface-associated Heparan Sulfate by Tryp-
sin or Heparin:
￿
The "S-labeled hepatoma cells were incubated with 100
Ag heparin/ml of medium for 30 min at 37°C, followed by an incubation with
100 ug trypsin/ml of PBS for 2-5 min at 37°C. The reaction was stopped by
theaddition of250,ug/ml ofsoybeantrypsin inhibitor. The incubation mixtures
were centrifuged to remove any detached cells, and trypsin-released proteogly-
cans were isolated from the supernatants. For quantitation of "S-labeled
glycosaminoglycans released by heparin or trypsin, samples were digested with
papain (26) and radiolabeled glycosaminoglycans were precipitated onto filter
papers with cetylpyridinium chloride (31).
Hydrophobic Chromatography of Proteoglycans:
￿
Solutions
of 'H-labeled heparan sulfate proteoglycans purified from (a) the medium of
cultured hepatoma cells, (b) the cell layer after solubilization with detergent
and (c) the trypsin-released material were made 2% cholate in 0.02 M Tris-
HCI, pH 7.3, by a procedure previously described (7). The samples were then
applied to a column (3 x 1 cm) of octyl-Sepharose and eluted in a stepwise
manner with 25-ml aliquots of0.02 M Tris-HCI buffer, pH 7.3, containing: (a)
0. l M NaCI, (b) 3.0 M NaCl, (c) 3.0 M NaCl and I % Triton X-100, and (d)
0.4% deoxycholate. This elution procedure resulted in the recovery ofat least
95% ofthe radioactivity applied to the column.
Affinity Chromatography on Fibronectin-Sepharose: Af-
finity chromatography of radiolabeled proteoglycans and isolated polysaccha-
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Immunofluorescent staining of hepa-
toma cells for heparan sulfate proteoglycans .
Hepatoma cells were stained for heparan sulfate
proteoglycan using an antibody raised against
basement membrane heparan sulfate proteogly-
can . x 1,100 .
ride chains on columns of fibronectin-Sepharose was performed as previously
described (7).
Binding of Exogenous Radiolabeled Glycosaminoglycans to
Hepatorna Cells :
￿
The binding ofadded radiolabeledglycosaminoglycans
to cultured hepatoma cells was investigated using a technique previously
described (5).
RESULTS
Distribution of Heparan Sulfate Proteoglycans
and Fibronectin in Rat Hepatoma Cells
Immunofluorescent staining of cultures of rat hepatoma
cells using anti-rat fibronectin indicated that the extracellular
fibronectin-containing matrix produced by cultures ofnormal
hepatocytes (32 ; S . Johansson and M . Höök, unpublished
observation) is lacking in the hepatoma cell cultures (not
shown) . Staining for heparan sulfate proteoglycan (Fig. 1)
indicated that this molecule is present on the hepatoma cells
but not in an extracellular matrix. These results point to a
concomitant loss of fibronectin and heparan sulfate from the
extracellular matrix, which is in keeping with previous reports
(8,33) .
Isolation of Proteoglycans Secreted by Cultured
Hepatoma Cells
Media obtained from cultured hepatoma cells incubated
for 48 h in the presence of [35S]sulfate or ['H]glucosamine
were subjected to anion-exchange chromatography on col-
umns of DEAE-Sephacel . Most of the ' SS radioactivity was
washed through the column, but some of the 35S-labeled
material bound to the DEAE-Sephacel and eluted as an
asymmetrical peak in the NaCl gradient (Fig. 2) . When
['H]glucosamine was used as the radioisotope, two peaks of
radioactivity were eluted in theNaCI gradient. The first peak,
which appeared shortly after the start of the gradient, was not
analyzed further. The elution position of the second peak
essentially coincided with that ofthe "S-labeled material (data
not shown) . Heparan sulfate constituted the major portion
(-80%) of the labeled material in this peak, as shown by the
susceptibility of the material to nitrous acid deamination
(Table I) .' Most of the remaining material was susceptible to
'When ['H]glucosamine is used for labeling of proteoglycan, the
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Fraction no.
FIGURE 2 Ion-exchange chromatography of "S-labeled medium
from hepatoma cell cultures . 5 ml of conditioned medium from
[' SS]sulfate-labeled hepatoma cultures were made up to 30 ml with
0.35 M NaCl in 0.05 M Tris-HCI, pH 8.0, and then applied to a
column (3 x 1 cm) of DEAE-Sephacel, which had been equilibrated
with the pH 8.0 buffer. The column was washed with 40 ml of 0.35
M NaCl in 0.05 M acetate buffer, pH 4.0, and eluted with a linear
gradient (150 ml) from 0.35 to 1 .5 M NaCl in acetate buffer, pH
4.0 . Fractions of 2.0 ml were collected and 0.05-ml samples were
analyzed for "S radioactivity (0--0); conductivity (-----) .
digestion with chondroitinase ABC and is tentatively identi-
fied as chondroitin sulfate (Table I) . The heparan sulfate
proteoglycans were isolated after digestion ofthe proteoglycan
mixture with chondroitinase ABC .
Structural Comparison of Heparan Sulfate
Proteoglycans Isolated from Cultured Hepatoma
Cells and from Rat Liver Microsomes
s IZE:
￿
The molecular sizes of ' SS-labeled heparan sulfate
proteoglycans isolated from the hepatoma cell culture me-
dium and from rat liver microsomes were compared by
chromatography on a column of Sepharose CL-4B eluted
with 4 M GuHCl . Both proteoglycans eluted as fairly broad
peaks, which indicates considerable heterogeneity in molecu-
lar size (Fig. 3) . The elution profile of the hepatoma proteo-
isotope is presumably incorporated into oligosaccharides as well as
into polysaccharides. These oligosaccharides are presumably not de-
graded by nitrous acid treatment of digestion with chondroitinase
ABC and would therefore be classified as "other" in Table I."S- or 3H-labeled Proteoglycans Produced by Hepatoma Cells
Newly synthesized proteoglycans were labeled with 'H or "S by incubation
of hepatoma cells in medium containing ['H]glucosamine or ['H]sulfate.
After 48 h incubation, the medium was removed and the cell layer was
solubilized as described in Materials and Methods. Radiolabeled proteogly-
cans from the media and the cell extracts were isolated by chromatography
on DEAE-Sephacel. The proteoglycans were identified as heparan sulfate or
chondroitin sulfate proteoglycan on the basis of their susceptibility to chon-
droitinase ABC digestion and nitrous acid deamination, respectively. Radio-
active material that resisted both treatments was designated "other."
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FIGURE 3
￿
Gel chromatography of 35S-labeled heparan sulfate pro-
teoglycans purified from hepatoma cell culture medium and rat
liver microsomes. Samples of hepatoma heparan [3sS]sulfate pro-
teoglycan from the culture medium (-; cpm x 10-') and rat liver
heparan [3sS]sulfate proteoglycan (- - -; cpm x 10-3) were applied
to a column (98 x 1 .2 cm) of Sepharose CL-4B equilibrated with 4
M GuHCI in 0.05 M Tris-HCI, pH 8.0, containing protease inhibitors.
The column was eluted with the same buffer at a flow rate of 4 ml/
h. Fractions of 1 .5 ml were collected and 0.5-ml samples were
analyzed for 3sS radioactivity.z The arrows indicate the elution
positions of the protein standards (phosphorylase b, 94,000 mol wt;
a-chain of fibrinogen, 70,000 mol wt; and the heavy chains of IgG,
53,000 mol wt, respectively).
glycans indicates the presence of two poorly separated sub-
populations: the peak of the major population eluted as a
broad peak at Ka, of 0.39 compared with a Ka~ of 0.44 for the
peak fraction of the rat liverproteoglycann2 By comparing the
elution positions of the 3'S-labeled proteoglycans with those
of the standard proteins, the relative molecular weights of the
rat liver proteoglycans and the hepatoma heparan sulfate
proteoglycans can be estimated to be 80,000 and 95,000,
respectively. When analyzed on a column (1 x 93 cm) of
z A degradation of hepatoma heparan sulfate proteoglycans was ob-
served when culture media containing [3sS]proteoglycans were incu-
bated at 37°C for long periods of time. It is therefore possible that the
second peak represents a slightly degraded form ofthe native proteo-
glycans.
Sepharose CL-4B, the major population of the hepatoma
proteoglycan eluted at a volume of62 ml, which is comparable
to the elution position of heparan sulfate proteoglycans syn-
thesized by cultured hepatocytes (see Fig. 3; reference 5).
The hepatoma heparan sulfate proteoglycans were degraded
by incubation with papain or alkali/borohydride, which is
consistent with a proteoglycan structure. Alkali/borohydride
treatment, which releases the labeled polysaccharide chains
from the core protein, yielded a product that was somewhat
smaller than that obtained after papain digestion, which
cleaves in the core protein. The elution positions after gel
chromatography on Sepharose CL-4B corresponded to Ka =
0.69 and Ka, = 0.62 for [3sS]polysaccharides obtained after
incubation ofthe hepatoma heparan sulfate proteoglycan with
alkali/borohydride and papain, respectively (data not shown).
On Sephadex G-200, the alkali-released polysaccharides
from the HTC medium heparan sulfate proteoglycan eluted
as a broad peak at a Ka of 0.29 compared with a Ke, of 0.32
obtained for heparan sulfate chains from normal rat liver
(data not shown). These elution positions correspondto those
of chondroitin sulfates with molecular weights of 19,000 and
16,000, respectively (29).
POLYANIONIC PROPERTIES: The polyanionic proper-
ties of heparan sulfate proteoglycans isolated from rat liver
microsomes, cultured hepatocytes and cultured hepatoma
cells, respectively, were compared by anion-exchange chro-
matography. Tritium-labeled heparan sulfate proteoglycans
isolated from conditioned media of the hepatoma cultures
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FIGURE 4 Ion-exchange chromatography of heparan sulfate pro-
teoglycans purified from hepatoma cell culture medium, rat liver
microsomes, and cultured rat hepatocytes. A sample of ['H]hep-
aran sulfate proteoglycan purified from hepatoma cell culture me-
dium was mixed with a sample of heparan [3sS]sulfate proteoglycan
purified from rat liver microsomes (A) or from cultured rat hepato-
cytes (B) and applied to a column (1 x 3 cm) of DEAE-Sephacel
equilibrated with 0.35 M NaCl in 0.05 M Tris-HCI, pH 8.0. The
column was washed with 20 ml of 0.35 M NaCl in 0.05 M acetate
buffer, pH 4.0, and eluted with a linear gradient (150 ml) from 0.35
to 1.2 M NaCl in acetate buffer, pH 4.0. Fractions of 2.0 ml were
collected and 0.5-ml samples were analyzed for 3H radioactivity
(-) and 3sS radioactivity (- - -); conductivity (-----).
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Proportions of radioactivity
(%
Heparan
sulfate
total cpm)
Chon-
droitin
sulfate
in
Other
Medium
[3sS]Sulfate 80 19 1
['H]Glucosamine 81 6 13
Cell layer
[3sS]Sulfate 71 25 4
[3H]Glucosamine 65 14 21were mixed with heparan ['SS]sulfate proteoglycans purified
from rat liver microsomes (Fig. 4A) or from cultured hepa-
tocytes (Fig. 4B) and applied to a column ofDEAE-Sephacel.
The column was eluted with a linear gradient of NaCl. The
hepatoma derived ['H]heparan sulfate proteoglycans were
eluted earlier and well separated from the rat liver ['SS]-
proteoglycans regardless ofwhether these were labeled in vivo
or in vitro, which demonstrates a difference in polyanionic
properties between the two proteoglycan species.
Sulfate and uronic acid residues constitute the negatively
charged groups in heparan sulfate, whereas glucosamine units
carrying unsubstituted amino units represent potential posi-
tive charges. Since the density of uronic acid units in heparan
sulfate is fixed, variations in polyanionic properties must
reside in differences in the number of sulfate groups and/or
exposed amino groups on glucosamine units.
The distribution ofN-deacetylated glucosamine residues in
the heparan sulfate chains was investigated by treating the
'H-labeled samples with nitrous acid under conditions that
cleave both N-sulfated and N-unsubstituted glucosamine
units, whereas N-acetylated glucosamine units are left intact
(see Materials and Methods). The deamination mixtures were
fractionated on a column ofSephadex G-50. As shown in Fig.
5, nitrous acid deamination of 'H-labeled heparan sulfate
isolated from rat liver microsomes resulted in the conversion
of the polysaccharide to fragments of low molecular weight.
On the other hand, degradation of the hepatoma heparan
sulfate with nitrous acid yielded, in addition to low molecular
weight fragments, oligosaccharides of intermediate size. This
suggests that there is a higher content of N-acetylated gluco-
samine units in the hepatoma heparan sulfate compared with
normal liver heparan sulfate. Consequently, the hepatoma
heparan sulfate must have a lower density ofsulfamino groups
compared with that of the polysaccharide isolated from nor-
mal liver.
Mechanism of Cell Association of the Hepatoma
Heparan Sulfate Proteoglycan
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FIGURE 5 Gel chromatography of nitrous acid deaminated 3H-
labeled heparan sulfate proteoglycans. Samples of ['H]heparan
sulfate proteoglycans purified from rat liver (- - -) and from hepa-
toma cell culture medium (-) were subjected to the combined
nitrous acid treatment described in Materials and Methods. The
mixtures were then neutralized and applied to a column (62 x 0.6
cm) of Sephadex G-50 equilibrated with 1 .0 M NaCl. The column
was eluted with the same buffer at a flow rate of 3 ml/h. Fractions
of 0.4 ml were collected and analyzed for sH radioactivity.
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To isolate these cell-associated proteoglycans, the cells were
solubilized in a buffer containing detergent and chromato-
graphed on a column of DEAE-Sephacel. An asymmetrical
peak of radioactivity was eluted at an ionic strength compa-
rable to that required for the elution of the medium proteo-
glycans. The compositional analysis of the cell-associated
glycosaminoglycans indicated that heparan sulfate was the
predominant (71 %) glycosaminoglycan (Table I).
SUSCEPTIBILITY TO TREATMENT WITH HEPARIN OR
TRYPSI N: To analyze the mode of association of heparan
sulfate proteoglycans with the hepatoma cell surface, cells
were incubated with heparin to displace receptor-bound pro-
teoglycan or with trypsin to release proteoglycans anchored
in the membrane via their core proteins. Less than 5% ofthe
cell-associated proteoglycans was released by heparin. It ap-
pears, therefore, that there are few or no heparan sulfate
proteoglycans bound to polysaccharide receptors on the hep-
atoma cells. On the other hand, up to 45% of the "S-labeled
glycosaminoglycans associated with the cell layer could be
released by incubation of the cells at 37°C with 100 jug/ml of
trypsin for 5 min. After this incubation period, the cells had
rounded up and a large proportion had detached from the
substratum. Samples of the trypsin-released material were
subjected to chondroitinase ABC digestion and nitrous acid
deamination, and the results indicated that -80% of the "S
radioactivity was associated with heparan sulfate.
HYDROPHOBIC CHROMATOGRAPHY ON OCTYL-SEPH-
AROSE: Radiolabeled heparan sulfate proteoglycans purified
from the medium ofcultured hepatoma cells, from detergent-
solubilized cells, and from the material released from the cells
by trypsin digestion were transferred to a buffer composed of
2% cholate in 0.02 M Tris-HCI, pH 7.3, and applied to
columns of octyl-Sepharose. The columns were eluted in a
stepwise manner with Tris-HCI buffers containing salt and/
or detergents. The results are illustrated in Fig. 6. Most of the
medium- and trypsin-released heparan sulfate proteoglycans
(90 and 86%, respectively) were eluted from the octyl-Sepha-
A
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FIGURE 6 Hydrophobic chromatography of [3H]heparan sulfate
proteoglycans synthesized by hepatoma cells. Samples of [3H]-
heparan sulfate proteoglycans purified from the hepatoma cell
culture medium, the cell layer, and released by mild trypsin treat-
ment of the cells were applied to a column (3 x 1 cm) of octyl-
Sepharose. The column was eluted in a stepwise manner with 25-
ml aliquots of 0.02 M Tris-HCI buffers, pH 7.3, containing salt
(striped bars: 1, 0.1 M NaCl; 2, 3.0 M NaCl) and then buffers
supplemented with detergent (black bars: 3, 3.0 M NaCl and 1%
Triton X-100; 4, 0.4% deoxycholate). The amount of 3H radioactivity
eluted is expressed as a percentage of the total radioactivity re-
covered from the column.
A considerable amount (-20%) of the radiolabeled glycos-
aminoglycans remained associated with the cell layer after E
removal of the medium from 'SS-labeled hepatoma cultures.
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FIGURE 7
￿
Affinity chromatography of labeled heparan sulfate pro-
teoglycans on columns of fibronectin-Sepharose. A sample of
[3H]heparan sulfate proteoglycan purified from rat liver was mixed
with a sample of heparan ["S]sulfate proteoglycan purified from
hepatoma cell culture medium and applied to a column (3 x 1 cm)
of fibronectin-Sepharose equilibrated with 0.04 M CsCl in 0.01 M
Tris-HCI, pH 7.5 .3 The column was washed with 20 ml of the same
buffer and then eluted with a linear gradient of 0.04-0.5 M CsCI in
0.01 M Tris-HCI, pH 7 .5. Fractions of 1 .0 ml were collected and
analyzed for 3H radioactivity (- - -) and 35S radioactivity
conductivity (-----).
rose column in buffers that disrupt ionic but not hydrophobic
interactions. In contrast, detergent was required to displace
the major proportion (62%) of cell-associated heparan sulfate
proteoglycan from the column. The finding that the detergent-
solubilized but not the trypsin-released proteoglycans bound
to the octyl-Sepharose by hydrophobic forces is consistent
with the hypothesis (see reference 6) that the cell-associated
heparan sulfate proteoglycans are anchored in the plasma
membrane via a hydrophobic segment ofthe core protein that
is cleaved off by trypsin.
Functional Differences between Heparan Sulfate
Proteoglycans Isolated from Normal Rat Liver and
from the Medium of Hepatoma Cultures
FIBRONECTIN INTERACTION: A sample of heparan
['SS]sulfate proteoglycans purified from hepatoma cell culture
media was mixed with a sample of ['H]heparan sulfate pro-
teoglycans obtained from rat liver microsomes and applied to
a column of fibronectin-Sepharose . All of the labeled material
bound to the column and was eluted in a CsCl gradient (see
Fig. 7). The "S-labeled hepatoma proteoglycan was eluted at
a lower concentration of CsCl than the 'H-labeled rat liver
proteoglycan.' Heparan sulfate chains released from the core
proteins by alkali/borohydride eluted from the fibronectin-
Sepharose at the same salt concentration as their correspond-
ing proteoglycans (data not shown). The observed difference
in elution position between the proteoglycans from the two
sources presumably reflects a difference in binding affinity.
BINDING TO HEPATOMA CELLS:
￿
Data described above
indicate that the heparan sulfate associated with the surface
of cultured hepatoma cells is not bound to the cells via a
polysaccharide-receptor interaction. This observation may re-
flect an absence offunctional receptors on the hepatoma cells
and/or a structural defect in the heparan sulfate produced by
3 The ionic strength of the buffer needed to elute ['H]heparin from
the fibronectin-Sepharose was the same whether the column was
eluted with a gradient of CsCI or NaCl.
FIGURE 8 Binding of labeled glycosaminoglycans and hepatoma
heparan sulfate proteoglycans to hepatoma cells. Hepatoma cells
were suspended in 0.5 ml of medium and incubated at 37°C with
[3 H]heparin (/,
￿
12,000 cpm), ['H]heparan sulfate from bovine
liver (p,
￿
17,000 cpm), or heparan ["S]sulfate proteoglycan from
hepatoma cell culture medium (",
￿
10,000 cpm) in a rotational
shaking incubator. The mixtures were incubated for the indicated
time periods and cells present in 0.2 ml of the suspensions were
isolated by centrifugation through a Percoll gradient medium and
assayed for associated radioactivity. The amount of radioactivity
that bound to the cells is expressed as a percentage of the total
radioactivity added to the cell suspension.
the hepatoma cells (i.e., reduced sulfation).
To analyze these possibilities, hepatoma cells were incu-
bated for various times in the presence of ['H]heparin,
['H]heparan sulfate isolated from bovine liver, and "S-labeled
heparan sulfate proteoglycans purified from hepatoma culture
media, respectively. The two 'H-labeled glycosaminoglycans
bound to the cells in a time-dependent manner, and maximal
binding occurred after 2 h of incubation (see Fig. 8). In
contrast, the hepatoma "S-labeled proteoglycan did not bind
to the cells. To exclude the possibility that the lack ofdetect-
able cell binding of the hepatoma proteoglycan was a result
of a low specific activity of the proteoglycans or was caused
by the presence ofan inhibitor in the hepatoma preparations
which interfered with polysaccharide-receptor binding, cells
were incubated with a mixture of 'H-labeled heparan sulfate
from bovine liver and heparan ['SS]sulfate proteoglycans de-
rived from the medium of the hepatoma cell cultures. The
presence of the hepatoma proteoglycan did not significantly
affect the binding of the bovine liver ['H]heparan sulfate to
the cells. Furthermore, hepatoma heparan sulfate proteogly-
cans did not bind to isolated rat hepatocytes (L. Kjell6n,
unpublished observations). Hence, the hepatoma cellscontain
a receptor capable ofbinding polysaccharides but the heparan
sulfate produced by these cells does not fulfill the structural
requirements for receptor interaction, presumably because of
its low sulfate content.
DISCUSSION
Previous studies (28) have shown that the rat liver heparan
sulfate proteoglycan has a molecular weight of 80,000 and is
composed of a core protein with a molecular weight of
20,000 to which four polysaccharide chains are attached. In
the present investigation we found that a heparan sulfate
proteoglycan isolated from the medium of hepatoma cells
cultures has essentially the same size (95,000 compared with
80,000) and that the polysaccharide chains isolated from rat
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tYliver and hepatoma proteoglycans also are of similar size
(-16,000 compared with ~19,000). It is therefore likely that
the general structure of the hepatoma proteoglycan conforms
to the model proposed for the rat liverproteoglycan. Previous
studies (34) of a heparan sulfate proteoglycan isolated from
an ascites hepatoma indicated that this proteoglycan con-
tained three to four polysaccharide chains attached to the core
protein.
The heparan sulfate synthesized by transformed cells gen-
erally has a reduced sulfate content compared with the hep-
aran sulfate produced by the untransformed counterparts.
Studies on cultured mouse 3T3 cells and their ßV40 trans-
formants indicate a transformation-dependent change in the
charge density of the heparan sulfate synthesized by these
cells (14, 15), which correlates with expression of the SV40-
specific T-antigen (16). Similarly, Nakamura et al. (35) have
shown that the AH-130 hepatoma cells produce large quan-
tities of a heparan sulfate with a low sulfate content. These
observations are confirmed in the present study, in which
cultured rat hepatoma cellsare shown to synthesize a heparan
sulfate that has a markedly reduced sulfate content compared
with that isolated from normal rat livers or from cultured
hepatocytes.
Attempts were made to identify the cause of the reduced
sulfation in the hepatoma heparan sulfate. The hepatoma
polysaccharide was found to contain an increased number of
N-acetyl groups and a decreased number of N-sulfate units
compared with rat liverheparan sulfate. The first stage in the
biosynthesis of heparan sulfate-like polysaccharides is the
formation of a polymer composed of alternating units of N-
acetyl glucosamine and glucuronic acids (30 and references
therein). Subsequent to, or along with, the formation of the
carbohydrate backbone, the polysaccharide is subjected to a
series of discrete polymer modification reactions initiated by
an N-deacetylation of N-acetyl glucosamine units and fol-
lowed by N-sulfation, glucuronic acid epimerization, and O-
sulfation of hexosamine and iduronic acid units. In the hep-
atoma cells the polymer formation reactions appear to pro-
ceed normally but the N-deacetylase does not seem to operate
as efficiently as in the hepatocyte. The N-deacetylase has
tentatively been identified as a regulatory enzyme (30) and
the extent of initial N-deacetylation appears to control the
overall polymer modification. Impaired N-deacetylation in
the biosynthesis ofheparan sulfate in the hepatoma cells could
therefore result in a low sulfate content of the final product.
The reduced sulfate content of the hepatoma heparan sul-
fate may affect the interactions ofthe proteoglycan with other
molecules. The distribution of the heparan sulfate proteogly-
cans in the hepatoma cell layer appears to be restricted to the
cells; no extracellular matrix is formed, as indicated by im-
munofluorescent staining. Previous studies have shown that
highly sulfated heparan sulfate-like polysaccharides enhance
the rate of binding offibronectin to collagen (36) and stabilize
the fibronectin-collagen complex (9). In the present study the
hepatoma heparan sulfate was shown by affinity chromatog-
raphy to have a markedly lower apparent affinity for fibro-
nectin compared with heparan sulfate from normal rat liver.
It therefore appears possible that heparan sulfate plays a role
in the process of matrix formation and that successful matrix
formation depends on a strong heparan sulfate-fibronectin
interaction. However, the role of heparan sulfate in matrix
formation remains speculative since it cannot be excluded
that other matrix components produced by the hepatoma
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cells may also be defective.
A number of studies have implicated glycosaminoglycans
in the regulation of cell proliferation (17-20). In particular,
mucopolysaccharides and proteoglycans isolated from normal
liver have been shown to reduce the rate of proliferation of
cultured hepatoma cells (21, 37). In the present investigation
heparan sulfate proteoglycans isolated from rat liver micro-
somes were found to bind directly to a component on the
hepatoma cell. This interaction resembles that between hep-
aran sulfate and specific polysaccharide receptors present on
the surface of hepatocytes, which has previously been char-
acterized in some detail (5, 38). Since the heparan sulfate
proteoglycan produced by the hepatoma cells was unable to
bind to the cell surface receptors, presumably because of its
low sulfate content, it is tempting to suggest that the observed
inhibitoryeffect ofnormal heparan sulfate on the proliferation
of hepatoma cells involves the polysaccharide-receptor inter-
action.
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